Apparatus and method for producing and automatically injecting H215O

Abstract: An apparatus for producing and automatically injecting H 2 ¹⁵O, comprises: a target box (1) adapted to be irradiated with a deuteron beam; a gas supplying device (21-26) for supplying a hydrogen gas and a nitrogen gas as raw-material gases to the target box; a radioactive-isotope conveying pipe (4) connecting the target box; and a vacuum pump (3) for maintaining the interior of the target box and the interior of the radioactive-isotope conveying pipe in a vacuum state. In addition, the apparatus further comprises an injection-fluid producing device (5) and an automatic injection (6) device, wherein the target box, the injection-fluid producing device and the automatic injection device are fluidly connected with one another.

Description: The present invention relates to a method of medical treatment using a radioactive isotope (RI), and more particularly to a production method and an injection device for using an RI having a short half life as an injection fluid. With respect to a conventional system, the ¹⁵O series has been taken up into a living body as an RI gas through an inhalation method. In this case, since the RI gas is inhaled through a mask, the RI gas can leak from the mask, so that there are cases where the background and stability of a positron emission tomography (PET) apparatus are impaired. In addition, with respect to the living body, since the RI gas is absorbed into blood vessels through the lungs, the period of inhalation becomes long, with the result that exposure has been great. Furthermore, since the aforementioned ¹⁵O series RI gases have short half lives of only two minutes or thereabouts, in order to be taken in as a gas through the lunge as describe above, it is necessary to use a large amount of RI gas, so that the operator's exposure has also been great. In addition, in a case where an H 2 15 O gas is used as an injection fluid, a ¹⁵O₂ gas is heated by using platinum or palladium as a catalyst, and an H₂ gas is also made to pass through the catalyst when the ¹⁵O₂ gas passes through the catalyst, so as to synthesize H 2 15 O. Then, a caponized compound is subjected to bubbling in physiological saline so as to produce an injection drug. However, since the half life is short, the efficiency has been poor. The International Journal of Radiation/Applications and Instrumentation Part A, Vol 38, No 8, 1987, pages 597-600, discloses a procedure for manufacturing H 2 15 O. JP-A-60004900 discloses a procedure for manufacturing H 2 15 O. The object of the present invention is to provide a safe and efficient method and an apparatus for rendering this method realizable, thereby overcoming the above-described problems. To attain the above-described object there is provided a device for producing H 2 15 O and injecting it into a living body, the device comprising: an apparatus for producing H 2 15 O, comprising a target box adapted to be irradiated with a deuteron beam, means for supplying a hydrogen gas and a nitrogen gas as raw-material gases to said target box, a radioactive-isotope conveying pipe connected to said target box, and a vacuum pump for maintaining the interior of said target box and the interior of said radioactive-isotope conveying pipe in a vacuum state; an injection-fluid producing device comprising a collecting bottle which is inversely erected, an H 2 15 O introducing pipe connected to the target box and which is open to a lower space of said collecting bottle in order to cause bubbling by blowing H 2 15 O into physiological saline in said collecting bottle, and a radioactive isotope detector for detecting the content of H 2 15 O contained in physiological saline in said collecting bottle; and a device for automatically injecting the injection fluid collected in the collecting bottle, comprising an injection needle, a syringe provided for sucking the injection fluid and sending the injection fluid to said injection needle, a plurality of three-way valves provided between said collecting bottle and said syringe and between said syringe and said injection needle for changing the direction of flow of the injection fluid, a microporous filter disposed between one of said three-way valves and said injection needle, a first bubble detector arranged to detect the presence or absence of bubbles in a pipe for sucking the injection fluid from said collecting bottle, and a second bubble detector arranged to detect the presence or absence of bubbles in the injection fluid immediately before the injection fluid is injected into a living body. According to the present invention there is also provided a method of preparing and injecting a radioactive isotope, the method including the steps of detecting an amount of a radioactive isotope in an injection fluid, comprising the steps of providing physiological saline in a collecting bottle, introducing H 2 15 O produced through nuclear reaction into said physiological saline and absorbing said H 2 15 O into said physiological saline, and detecting whether a content of H 2 15 O contained in said physiological saline is reached a predetermined radiation amount by means of a radioactive isotope detector; and detecting the presence or absence of bubbles in the injection fluid, comprising the steps of detecting bubbles in a pipe connected to a syringe for sucking and conveying the injection fluid, by means of a first bubble detector, detecting bubbles in a pipe located immediately before an injection needle by means of a second bubble detector, and making safety doubly assured by stopping the operation of said syringe in the case where the bubbles are detected by said first bubble detector or said second bubble detector. As described above, it is possible to produce an injection fluid of a required amount immediately before injection and to execute the injection immediately. In addition, it is possible to cause the injection fluid to reach an affected part of a living body directly through blood vessels. Accordingly, the period of diagnosis can be reduced as compared with a conventional gas inhalation method. In the drawings:- Fig. 1 is a schematic diagram of an apparatus for producing H 2 15 O; Fig. 2 is a schematic diagram of an injection-fluid producing device and an automatic injection device; Fig. 3 is a diagram illustrating the state of operation in each step in the injection-fluid producing device and the automatic injection device; Fig. 4 is a flowchart of each step; and Fig. 5 is a diagram illustrating the state of operation of a sampling step. First, a description will be given of a method of producing H 2 15 O and an apparatus thereof. Fig. 1 is a schematic diagram of an apparatus for producing H 2 15 O. This apparatus comprises a target box 1, a gas supplying device 2, an RI conveying pipe 4, and a vacuum pump 3 for reducing the pressure within the target box 1 and the RI conveying pipe 4. The gas supplying device 2 includes a raw-material gas cylinder 21 in which H₂ and N₂ are mixed, a conveying gas cylinder 22 for using an He gas, a pressure-regulating valve 23 and a solenoid valve 24 that are disposed midway in a pipe leading from the gas cylinders 21, 22 to the target box 1, a solenoid valve 25 disposed at an outlet of the raw-material gas cylinder 21, and a solenoid valve 26 disposed at an outlet of the conveying gas cylinder 22. A solenoid valve 41 is disposed in the RI conveying pipe 4 at an outlet of the target box 1, and after the portion of the RI conveying pipe 4 downstream of this solenoid valve 41 is branched off; the vacuum pump 3 is connected thereto via a solenoid valve 42. Furthermore, a pipe is provided between the branching point and a solenoid valve 53 of an injection-fluid producing device 5. Since the RI gas having radioactivity passes through the interior of the RI conveying pipe 4, the exterior thereof is provided with shielding against radioactivity. A description will now be given of the action (including a method of operation) of the above-described apparatus for producing H 2 15 O. First, the solenoid valves 25, 26 and the solenoid valve 53 provided in the injection-fluid producing device 5 are closed, the interior of the target box 1 and the interior of the RI conveying pipe 4 and the like are set in a vacuum state by means of the vacuum pump 3, and cleaning is carried out. Then, the solenoid valve 42 is closed, the solenoid valve 25 is opened, and the raw-material gas is filled in the target box 1 and the RI conveying pipe 4. Subsequently, the above-described cleaning and filling of the raw-material gas are repeated a number of times so as to effect cleaning sufficiently. After the above cleaning step is accomplished, the solenoid valve 41 is closed, the raw-material gas which is regulated in a predetermined pressure by the pressure-regulating valve 23 is filled in the target box 1, the solenoid valve 24 is closed, and the operation is set in a standby state. The raw-material gas in the target box 1 is irradiated with a deuteron beam generated by a cyclotron at a required timing. Through this irradiation, the raw-material gas undergoes the following nuclear reaction so that H 2 15 O is produced. That is, After irradiation, the solenoid valve 41 and 53 are opened, and H 2 15 O thus produced is conveyed at a stroke to the injection-fluid producing device 5. In this case, H 2 15 O remaining in the target box 1 is conveyed completely to the injection-fluid producing device 5 by means of the helium gas in the conveying gas cylinder 22. A description will now be given of the injection-fluid producing device 5. This device is enclosed by a dotted-chain line in Fig. 2, and a collecting bottle 51 which is inversely erected and a fluid accumulating bottle 52 which is normally erected are fluidly communicated with each other by means of a capillary tube in such a manner as to connect together an upper space in the collecting bottle 51 and an upper space in the fluid accumulating bottle 52 by penetrating their caps. In addition, the pipe connected to the RI conveying pipe 4 through the solenoid valve 53 penetrates the cap of the collecting bottle 51 and is open in a lower space of its interior. Further, a pipe for penetrating the cap of the collecting bottle 51 and communicating the lower space of the collecting bottle 51 with an automatic injection device 6 is provided so as to send the injection-fluid to the automatic injection device 6. Meanwhile, in addition to the pipe leading from the collecting bottle 51 and penetrating the cap of the fluid accumulating bottle 52, a pipe connected to a three-way valve 54 is provided to the fluid accumulating bottle 52. A microporous filter 55 is connected to one of the other two ports of this three-way valve 54 and is arranged to take in the room air, while the other is arranged to discharge an exhaust gas. Furthermore, an RI detector 56 is provided in proximity to the collecting bottle 51. Meanwhile, the automatic injection device 6 is enclosed by a two-dotted chain line in Fig. 2, and is connected to a three-way valve 61 by means of pipe leading from the lower portion of the space in the collecting bottle 51 and penetrating its cap. A three-way valve 62 is connected to one of the other two ports of the three-way valve 61, and a injection needle 64 is connected to this port of the three-way valve via a microporous filter 63. In addition, a three-way valve 65 is connected to one of the other ports of the three-way valve 62, and a syringe 66 is connected to one of the other ports of the three-way valve 65, while a pipe leading to a waste fluid bottle 67 is connected to still another port thereof. Furthermore, a first bubble detector 68 is provided to the pipe between the three-way valve 61 and the collecting bottle 51, while a second bubble detector 68a is provided to the pipe between the three-way valve 62 and the microporous filter 63. It should be noted that an external physiological saline tank 7 is connected to one of the ports of the three-way valve 61. A description will now be given of the action (operation) of the injection-fluid producing device 5 and the automatic injection device 6. Disposable parts are used for all the bottles 51, 52, 67, the syringe 66, the injection needle 64, the microporous filter 63, and the three-way valves 61, 62, 65 that are used for the above-described injection-fluid producing device 5 and automatic injection device 6, as well as all the pipes other than the H 2 15 O introducing pipe among the pipes that are in contact with the injection fluid. Fig. 3 is a diagram explaining the action of each operation (step) of the injection-fluid producing device 5 and the automatic injection device 6, and Fig. 4 is a flowchart of the steps. Each action (operation) will be described with reference to this flowchart. Step 1: All the disposable parts are replaced with new ones. These disposable parts include the collecting bottle 51, the fluid accumulating bottle 52, the physiological saline tank 7, the three-way valves 61, 62, 65, the syringe 66, the waste fluid bottle 67, the microporous filter 63, the injection needle 64, and the pipes connecting the respective adjacent members. Step 2: The physiological saline is allowed to fall by its own weight and to flow from the physiological saline tank 7 to the waste fluid bottle 67 so as to vent the air existing therebetween. This state is shown by a darkened portion in Fig. 3. Hereinafter, the portions where the gas and fluid flows in each step are indicated by darkened portions. Step 3: Physiological saline is sucked into the syringe 66 from the physiological saline tank 7 via the three-way valve 61, 62, 65 by means of a syringe driving device 66a. Step 4: The physiological saline sucked in Step 3 is allowed to flow from the syringe 66 to the injection needle 64 via the three-way valves 65 and 62 so as to vent the air existing therebetween by means of the syringe driving device 66a. In this case, it is possible to completely vent the air by repeating Steps 1 to 4 any number of times. Step 5: The physiological saline is allowed to flow from the physiological saline tank 7 via the three-way valves 61, 62, 65 so as to be sucked by the syringe 66. Step 6: The physiological saline sucked in Step 5 is allowed to flow via the three-way valves 65, 62, 61 so as to be transferred to the collecting bottle 51. Step 7: H 2 15 O together with the conveying gas is sent from the target box 1 to the collecting bottle 51 via the RI conveying pipe 4 and the solenoid valve 53. The conveying gas other than H 2 15 O absorbed in the collecting bottle 51 is accumulated in a waste gas cylinder via the fluid accumulating bottle 52 and the three-way valve 54. While H 2 15 O together with the conveying gas is being sent, the RI detector detects the amount of H 2 15 O absorbed, and Step 7 is continued until a predetermined amount is reached. When the predetermined amount is reached and a predetermined injection fluid is obtained, the operation proceeds to Step 8. Step 8: The injection fluid in the collecting bottle 51 is sucked by the syringe 66 in such a manner that H 2 15 O is accumulated in a coil portion 69 of the pipe via the three-way valves 61, 62, 65. In this case, since the pipe provided between the collecting bottle 51 and the three-way valve 61 is so arranged that the injection fluid passes through the photoelectric-type bubble detector 68, the presence or absence of bubbles in the injection fluid being sent is detected. If the bubbles are not detected, the operation proceeds to Step 9, and if they are detected, the sucking operation of the syringe 66 is stopped. In addition, when the injection fluid in the collecting bottle 51 is sucked by the syringe 66, air in the room flows into the collecting bottle 51 via the microporous filter 55, the three-way valve 54, and the fluid accumulating bottle 52 so as to prevent the pressure within the collecting bottle 51 from being reduced. Step 9: H 2 15 O accumulated in the coil portion 69 is allowed to reach the injection needle 64 via the three-way valve 65, 62 and the microporous filter 63 by means of the injection fluid sucked by the syringe 66, so as to be injected into the living body. In this case, a check is made by the bubble detector 68a for detecting the presence or absence of bubbles. In this case, since the operation is usually repeated a number of times in clinical diagnosis using H 2 15 O, air venting can be omitted, and the operation starting with Step 5 can be repeated to reduce time. A series of operation is completed when the administration of a number of injections is completed. It should be noted that, after completion of administration to the living body or prior to the administration, as shown in diagrams explaining sampling steps shown in Fig. 5, sampling can be effected as shown below, and an inspection for administration to a living body can be conducted. (1) Physiological saline is sucked into the syringe 66. (2) The physiological saline is allowed to enter the collecting bottle 51. (3) The physiological saline is sucked into the syringe 66 from the collecting bottle 51. (4) If a three-way valve 70 is interposed between the microporous filter 63 and the injection needle 64, it is possible to obtain a sample by changing over the three-way valve 70 without removing the injection needle 64. Needless to say, by pressing a button for sampling, the aforementioned Steps (1) to (4) are automatically operated. With respect to the above-described steps, the changeover of the solenoid valve 53 and the three-way valves 54, 61, 62, 65 and the vertical movement of the syringe 66 can be automatically effected simply by pressing an operation button of an unillustrated controller. In addition, since if bubbles are present in the injection fluid, an injection into the living body cannot be effected under any circumstance. Accordingly, at the time when the injection fluid is sucked into the syringe 66 from the collecting bottle 51, the presence or absence of bubbles is detected by the photoelectric-type bubble detector 68, and if the bubbles are present, the sucking operation of the syringe 66 is stopped. In Step 9, at the time of executing an injection, the presence or absence of bubbles is checked by the bubble detector 68a, and if the bubbles are present, the injecting operation of the syringe 66 is stopped. In the case where the just-mentioned operation has occurred, a reset is made and the operation is redone starting with Step 1. In addition, as for the injection fluid, air trapping and sundry bacteria processing are conducted by means of the microporous filter 63 located downstream of the injection needle 64. Furthermore, since the speed of injection by means of the syringe 66 is made variable, it is possible to execute an injection at a speed corresponding to the state of the living body. It should be noted that since the ¹⁵O series has a half life of two minutes or thereabouts, the arrangement provided is such that, in order to fix the injection period, the timer of the controller is started to count down after sucking the injection fluid into the syringe 66 in Step 8, thereby prompting the operator to execute an injection. This timer is so arranged that settings can be made variably depending on conditions. As described above, since it is possible to automatically inject an RI into the living body speedily and under a clean condition, the following advantages can be obtained: 1) Because of speediness, it does not take much time, and it is unnecessary to produce an RI in large quantities by a cyclotron. 2) Since the RI is not produced in large quantities, and an injection can be effected automatically, exposure of the operator can be reduced to a remarkable degree. 3) Since an injection into a living body is effected directly, the period until the RI reaches the affected site via blood vessels can be reduced, and the period of diagnosis can therefore be reduced. In addition, since exposure of the living body can be alleviated substantially, although diagnosis using a ¹⁵O series gas has up until now been possible only once, diagnosis can be conducted a number of times, so that the reliability of diagnosis of such as malignant tumors can be enhanced. 4) Since the detection of bubbles in the injection fluid is carried out at two points, the operator can engage in the operation at ease. 5) By incorporating a sampling step, it is possible to inspect the drug administered (H 2 15 O) at any time during an operation.

Claims: A device for producing H 2 15 O and injecting it into a living body, the device comprising: an apparatus for producing H 2 15 O, comprising a target box (1) adapted to be irradiated with a deuteron beam, means (21-26) for supplying a hydrogen gas and a nitrogen gas as raw-material gases to said target box, a radioactive-isotope conveying pipe (4) connected to said target box, and a vacuum pump (3) for maintaining the interior of said target box and the interior of said radioactive-isotope conveying pipe in a vacuum state; an injection-fluid producing device comprising a collecting bottle (51) which is inversely erected, an H 2 15 O introducing pipe connected to the target box (1) and which is open to a lower space of said collecting bottle in order to cause bubbling by blowing H 2 15 O into physiological saline in said collecting bottle, and a radioactive isotope detector (56) for detecting the content of H 2 15 O contained in physiological saline in said collecting bottle; and a device for automatically injecting the injection fluid collected in the collecting bottle, comprising an injection needle (64), a syringe (66) provided for sucking the injection fluid and sending the injection fluid to said injection needle, a plurality of three-way valves (61,62) provided between said collecting bottle and said syringe and between said syringe and said injection needle for changing the direction of flow of the injection fluid, a microporous filter (63) disposed between one of said three-way valves and said injection needle, a first bubble detector (68) arranged to detect the presence or absence of bubbles in a pipe for sucking the injection fluid from said collecting bottle, and a second bubble detector (68a) arranged to detect the presence or absence of bubbles in the injection fluid immediately before the injection fluid is injected into a living body. A method of preparing and injecting a radioactive isotope, the method including the steps of detecting an amount of a radioactive isotope in an injection fluid, comprising the steps of providing physiological saline in a collecting bottle, introducing H 2 15 O produced through nuclear reaction into said physiological saline and absorbing said H 2 15 O into said physiological saline, and detecting whether a content of H 2 15 O contained in said physiological saline is reached a predetermined radiation amount by means of a radioactive isotope detector; and detecting the presence or absence of bubbles in the injection fluid, comprising the steps of detecting bubbles in a pipe connected to a syringe for sucking and conveying the injection fluid, by means of a first bubble detector, detecting bubbles in a pipe located immediately before an injection needle by means of a second bubble detector, and making safety doubly assured by stopping the operation of said syringe in the case where the bubbles are detected by said first bubble detector or said second bubble detector.

Inventors: HANDA MASAHIKO, KANNO IWAO, MIZUNO AKIRA, MURAKAMI MATSUTARO, SUGAWAR TADASU, TODA YOHJIRO, HANDA, MASAHIKO, KANNO, IWAO, MIZUNO, AKIRA, MURAKAMI, MATSUTARO, SUGAWAR, TADASU, TODA, YOHJIRO, Handa, Masahiko, c/o Chiyoda Safety Appliance Ltd., Kanno, Iwao, c/o Res. Inst. Brain, Mizuno, Akira, c/o Chiyoda Safety Appliance Ltd., Murakami, Matsutaro, c/o Res. Inst. Brain, Sugawar, Tadasu, c/o The Japan Steel Works Ltd, Toda, Yohjiro, c/o The Japan Steel Works Ltd
Applicants: JAPAN STEEL WORKS LTD, UEMURA KAZUO, THE JAPAN STEEL WORKS, LTD., UEMURA, KAZUO
Application year: 1991
Main classification: G21G1
IPC codes: G21G1